Your browser doesn't support javascript.
loading
A strategy to enhance SERS detection sensitivity through the use of SiO2 beads in a 1536-well plate.
Chen, Jiadong; Yu, Qian; Lu, Mengdan; Jeon, Chang Su; Pyun, Sung Hyun; Choo, Jaebum.
Afiliación
  • Chen J; Department of Chemistry, Chung-Ang University, Seoul, 06974, South Korea.
  • Yu Q; Department of Chemistry, Chung-Ang University, Seoul, 06974, South Korea.
  • Lu M; Department of Chemistry, Chung-Ang University, Seoul, 06974, South Korea.
  • Jeon CS; R&D Center, Speclipse Inc., Seongnam, 13461, South Korea.
  • Pyun SH; R&D Center, Speclipse Inc., Seongnam, 13461, South Korea. ceo@speclipse.com.
  • Choo J; Department of Chemistry, Chung-Ang University, Seoul, 06974, South Korea. jbchoo@cau.ac.kr.
Anal Bioanal Chem ; 415(24): 5939-5948, 2023 Oct.
Article en En | MEDLINE | ID: mdl-37589939
ABSTRACT
The development of rapid and accurate assays is crucial to prevent the rapid spread of highly contagious respiratory infections such as coronavirus (COVID-19). Here, we developed a surface-enhanced Raman scattering (SERS)-enzyme-linked immunosorbent assay (ELISA) method that allows for the screening of multiple patient samples with high sensitivity on a 1536-well plate. As the well number on the ELISA well plate increases from 96 to 1536, the throughput of the assay increases but the sensitivity decreases due to the low number of biomarkers and the increase in non-specific binding species. To address this problem, silica (SiO2) beads were used to increase the surface-to-volume ratio and the loading density of biomarkers, thereby enhancing sensitivity. Using a three-dimensional gold nanoparticle (AuNP)@SiO2 SERS assay platform on a 1536-well plate, an immunoassay for the nucleocapsid protein biomarker of SARS-CoV-2 was performed and the limit of detection (LoD) decreased from 273 to 7.83 PFU/mL compared to using a two-dimensional assay platform with AuNPs. The proposed AuNPs@SiO2 SERS immunoassay (SERS-IA) platform is expected to dramatically decrease the false-negative diagnostic rate of the currently used lateral flow assay (LFA) or ELISA by enabling the positive diagnosis of patients with low virus concentrations.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Revista: Anal Bioanal Chem Año: 2023 Tipo del documento: Article País de afiliación: Corea del Sur

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Revista: Anal Bioanal Chem Año: 2023 Tipo del documento: Article País de afiliación: Corea del Sur